Price $2.19 |
Market Cap
35M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.8
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-14.4K
|
FCF
-1.0
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-30.90%
|
ROI
-
|
|
ROA
-29.00%
|
EPS Growth
35.00%
|
Current Ratio
15.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Neuroone Medical Technologies (NMTC) | $1.35 | - | - | 20M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $0.60 | - | - | 93M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.21 | - | - | 54.1M | Strong Buy |
| Biomerica Inc (BMRA) | $2.93 | - | - | 44.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.94 | - | - | 106.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
